Search for: "State v. Jan G."
Results 1 - 20
of 583
Sort by Relevance
|
Sort by Date
8 Jun 2024, 5:20 pm
E. coli O157:H7 is one of thousands of serotypes Escherichia coli.[1] The combination of letters and numbers in the name of the E. coli O157:H7 refers to the specific antigens (proteins which provoke an antibody response) found on the body and tail or flagellum[2] respectively and distinguish it from other types of E. coli.[3] Most serotypes of E. coli are harmless and live as normal flora in the intestines of healthy humans and… [read post]
23 May 2024, 1:23 pm
A lower court in March ordered the map to be used for the 2024 elections, after the Supreme Court failed to rule in the case by a proposed Jan. 1 deadline. [read post]
3 May 2024, 8:11 am
According to that archive, the supposedly "original" blogspot post purports to have been published Jan. 30, 2024, more than three weeks before the Fourth Circuit opinion (which the post quotes) was released. [read post]
30 Apr 2024, 3:12 pm
E. coli O157:H7 is one of thousands of serotypes Escherichia coli.[1] The combination of letters and numbers in the name of the E. coli O157:H7 refers to the specific antigens (proteins which provoke an antibody response) found on the body and tail or flagellum[2] respectively and distinguish it from other types of E. coli.[3] Most serotypes of E. coli are harmless and live as normal flora in the intestines of healthy humans and… [read post]
24 Apr 2024, 5:57 am
(Some media reports state he was holding up a small crucifix.) [read post]
14 Apr 2024, 1:05 pm
Co. v. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
9 Apr 2024, 2:41 pm
Hearing No. 16002409MD (LIRC Jan. 20, 2017), the Commission held that the requirements for being a driver for a [read post]
9 Apr 2024, 10:32 am
Pix credit here The question of the photograph has been at the center of modernity, and now deeply embedded in the reconsideration of the intersubjectivity of the person (and social collectives) in their encounters with the simulacra of the virtual and its generative consciousness (Jan Broekman, Knowledge in Change (Springer, 2023); Larry Catá Backer, 'The Soulful Machine' Int'l J. [read post]
27 Mar 2024, 3:39 pm
Origin and Meaning of the Anti-Power-Concentration Principle In Seila Law v. [read post]
24 Mar 2024, 9:01 pm
Today, Columbia is honoring Jack Coffee, a leader of securities law scholarship and policy. [read post]
21 Mar 2024, 1:01 pm
United States, 919 F. [read post]
18 Mar 2024, 6:00 am
By: Laurie E. [read post]
14 Mar 2024, 10:07 am
Last week, Bayer broke its Philadelphia losing streak, with a win in Kline v. [read post]
12 Mar 2024, 3:36 am
[7] See, e.g., Asset-Backed Securities, 70 FR 1506 (Jan. 7, 2005). [read post]
6 Mar 2024, 4:15 pm
Weisman v. [read post]
4 Mar 2024, 8:52 pm
” David G. [read post]
4 Mar 2024, 5:56 pm
The information will not be publicly available, but FinCEN is authorized to disclose the information: The act became effective Jan. 1. [read post]
29 Feb 2024, 3:48 pm
United States, the Court found the terms of the solicitation violated the SBA regulations regarding the evaluation of mentor-protégé offerors.[6] Specifically, the SBA regulations regarding mentor-protégé offerors states, “A procuring activity may not require the protégé firm to individually meet the same evaluation or responsibility criteria as that required of other offerors generally. [read post]
15 Feb 2024, 9:05 pm
Actual or potential conflicts would include: The nature of the sponsor’s contingent compensation or security ownership (g., where the security owned is purchased at a price substantially lower than the price paid by public security holders) that may induce the sponsor and affiliates to pursue a business combination transaction that would not necessarily benefit the shareholders. [read post]
